Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
20 April 2024 | Story Anthony Mthembu | Photo Charl Devenish
Rea Parkies
Dr Reabetswe Parkies, Senior Officer in Marketing within the Faculty of Economic and Management Sciences at the University of the Free State (UFS), graduates with a PhD in Business Management at the April 2024 graduations.

The April 2024  graduations at the University of the Free State (UFS) mark a significant moment for graduates in the Faculty of Economic and Management Sciences (EMS),  including Dr Reabetswe Parkies, whose journey in attaining a PhD in Business Management has been one of dedication and perseverance.

Reflecting on the upcoming ceremony, Dr Parkies expressed mixed emotions, encapsulating the essence of her journey: ‘’As I prepare to walk across that stage, I'm filled with a mixture of emotions—excitement, pride, nostalgia, and perhaps a hint of apprehension about what lies ahead.’’ This moment represents the culmination of years of hard work and commitment to her academic pursuits.

Dr Parkies’s doctoral thesis, titled “Student self-employment in South Africa: A triple helix model, entrepreneurial competence and social support perspective,” delves into the complex dynamics of student entrepreneurship within the South African context. Her study aims to develop a comprehensive model for understanding self-employment, incorporating factors such as entrepreneurial competence, social support, and the role of the university, industry and government initiatives.

A culmination of years of hard work

The path to achieving her PhD was not without its challenges. Balancing her responsibilities as a Senior Officer in Marketing at the UFS with the demands of academic research required meticulous time management and personal sacrifice. ‘’As time went on, I found my rhythm and developed strategies to become more efficient and effective,’’ Dr Parkies explained. She credits her successful completion of the PhD to the unwavering support of her supervisors and her determination.

As she prepares to celebrate this milestone, Dr Parkies looks ahead to future contributions to her field. ’’By delving deeper into my area of expertise, I aim to uncover new insights and share these findings with the academic community through scholarly articles,’’ she remarked, emphasising her commitment to ongoing research and knowledge dissemination.

Dr Reabetswe Parkies's achievement serves as an inspiration to aspiring scholars and underscores the importance of perseverance and dedication in pursuing academic excellence. Her journey exemplifies the ethos of the University of the Free State in fostering academic growth and scholarly inquiry. 

News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept